Allan Reine

Officer, PALVELLA THERAPEUTICS, INC.

Companies

Prime Medicine, Inc.Board member May 19, 2025 to now¹
Prime Medicine, Inc.Chief executive officer May 19, 2025 to now¹
Prime Medicine, Inc.Chief financial officer Jan 19, 2024 to Apr 17, 2026²
Foghorn Therapeutics Inc.Chief financial officer Oct 22, 2020 to Jan 17, 2024³
PALVELLA THERAPEUTICS, INC.Chief financial officer Feb 26, 2018 to Feb 28, 2019⁴
PALVELLA THERAPEUTICS, INC.Officer Aug 11, 2017 to Aug 17, 2017⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Prime Medicine, Inc. PRME125,000 shares⁶$477.5K at $3.82May 21, 2025
Foghorn Therapeutics Inc. FHTX53,784 shares⁷$100.8K at $1.88Jan 17, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

May 21, 2025Bought 125,000 shares at $1.18 of Prime Medicine, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPrime Medicine, Inc., Board member
2
SEC EDGARPrime Medicine, Inc., Chief financial officer
3
SEC EDGARFoghorn Therapeutics Inc., Chief financial officer
4
SEC EDGARPALVELLA THERAPEUTICS, INC., Chief financial officer
5
SEC EDGARPALVELLA THERAPEUTICS, INC., Officer
6
SEC EDGARPrime Medicine, Inc. shares after the filing of May 21, 2025
7
SEC EDGARFoghorn Therapeutics Inc. shares after the filing of Jan 17, 2024